Filtered By:
Source: Medscape Allergy Headlines
Condition: Autoimmune Disease
This page shows you your search results in order of date.
Order by Relevance | Date
Total 23 results found since Jan 2013.
Ginger Consumption May Mitigate Neutrophil Dysfunction Ginger Consumption May Mitigate Neutrophil Dysfunction
An oral ginger extract was associated with reduced action of the neutrophil activity associated with the development of autoimmune and inflammatory diseases.Medscape Medical News
Source: Medscape Allergy Headlines - September 22, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
European Commission Approves First Tocilizumab Biosimilar European Commission Approves First Tocilizumab Biosimilar
The biosimilar, commercially called Tyenne, is indicated to treat several autoimmune diseases as well as cytokine release syndrome and COVID-19.Medscape Medical News
Source: Medscape Allergy Headlines - September 21, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease
CAR –T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.Medscape Medical News
Source: Medscape Allergy Headlines - August 24, 2023 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Researchers Seek to Understand Post-COVID Autoimmune Risk Researchers Seek to Understand Post-COVID Autoimmune Risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.Medscape Medical News
Source: Medscape Allergy Headlines - May 1, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Health Plans Get Very Poor Scores for Access to Autoimmune Drugs Health Plans Get Very Poor Scores for Access to Autoimmune Drugs
Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune diseases, according to the analysis.Medscape Medical News
Source: Medscape Allergy Headlines - February 14, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Docs Urge Screening for Autoimmune Disorders in Celiac Disease Docs Urge Screening for Autoimmune Disorders in Celiac Disease
Many advocates aren ' t waiting for consensus guidelines to weigh in on this approach, citing the substantial health gains that early diagnosis and treatment can produce.Medscape Medical News
Source: Medscape Allergy Headlines - November 16, 2022 Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news
Autoimmune Diseases Linked to Spike in Post-MI Events Autoimmune Diseases Linked to Spike in Post-MI Events
The findings highlight the need for evidence-based screening and management guidelines for cardiovascular disease in these high-risk patients, an observer says.Medscape Medical News
Source: Medscape Allergy Headlines - September 15, 2022 Category: Allergy & Immunology Tags: Cardiology News Source Type: news
Vitamin D Supplements Cut Risk for Autoimmune Disease Vitamin D Supplements Cut Risk for Autoimmune Disease
The VITAL study assessed the effects of vitamin D and omega-3 fatty acid supplements on autoimmune disease incidence.Medscape Ob/Gyn
Source: Medscape Allergy Headlines - February 16, 2022 Category: Allergy & Immunology Tags: Internal Medicine Commentary Source Type: news
The Trick of Treating Cancer in Autoimmune Diseases The Trick of Treating Cancer in Autoimmune Diseases
For patients without a healthy immune system, immunotherapy could supercharge symptoms, but a new study is shedding light on how to go about treating cancer in patients with autoimmune diseases.Medscape Medical News
Source: Medscape Allergy Headlines - November 22, 2019 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Attacking Autoimmunity Through the Gut: Folly or Science? Attacking Autoimmunity Through the Gut: Folly or Science?
People with autoimmune disease are growing tired of waiting for conventional therapies to work and are turning to functional medicine to help manage their symptoms.Medscape Medical News
Source: Medscape Allergy Headlines - October 25, 2019 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news
Anti-TNF Agents Linked to Increased Risk of IBD Anti-TNF Agents Linked to Increased Risk of IBD
A new study finds that patients with autoimmune disease treated with anti- tumor necrosis factor alpha have an increased risk of developing inflammatory bowel disease.Medscape Medical News
Source: Medscape Allergy Headlines - July 15, 2019 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Anti-TNF Agents Linked to Increased Risk for IBD Anti-TNF Agents Linked to Increased Risk for IBD
A new study finds that patients with autoimmune disease treated with anti- tumor necrosis factor alpha have an increased risk of developing inflammatory bowel disease.Medscape Medical News
Source: Medscape Allergy Headlines - July 15, 2019 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Fatigue in Lupus and Other Autoimmune Skin Diseases Fatigue in Lupus and Other Autoimmune Skin Diseases
How does fatigue impact quality-of-life in patients with cutaneous lupus erythematosus and other skin-limited autoimmune diseases?The British Journal of Dermatology
Source: Medscape Allergy Headlines - July 15, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news
FDA OKs First Treatment for Children With LEMS FDA OKs First Treatment for Children With LEMS
Amifampridine (Ruzurgi) is an oral potassium channel blocker indicated for children and adolescents aged 6 years to less than 17 years with the rare autoimmune disease.FDA Approvals
Source: Medscape Allergy Headlines - May 8, 2019 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Alert Source Type: news
Adalimumab Appears Safe for Treating Pediatric Patients With Autoimmune Disease Adalimumab Appears Safe for Treating Pediatric Patients With Autoimmune Disease
Adalimumab appears to be safe for treating pediatric patients with polyarticular juvenile idiopathic arthritis (JIA), enthesitis-related arthritis (ERA), psoriasis and Crohn ' s disease (CD), according to data from company-sponsored clinical trials.Reuters Health Information
Source: Medscape Allergy Headlines - August 10, 2018 Category: Allergy & Immunology Tags: Pediatrics News Source Type: news
